巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    GT Biopharma

    GTBP
    2.890
    0.060
    2.03%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・GT Biopharma - 延遲價格・最後更新於 01/07 12:14
    最高位
    3.040
    最低位
    2.800
    開市價
    --
    前收市價
    2.950
    成交量(千)
    4.36
    成交額(百萬)
    0.11
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    88.15
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    15.440 - 1.510
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    GT Biopharma
    證券代碼
    GTBP.US
    所屬板塊
    Biotechnology
    公司業務
    GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
    發行量
    30500717
    公司總部
    8000 Marina Boulevard, Suite 100
    公司網址
    https://www.gtbiopharma.com
    公司電郵
    info@oxis.com
    公司電話
    +1 415 919-4040
    暫無內容

    關於

    GT Biopharma(GTBP.US)所屬的行業板塊為Biotechnology。
    GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
    詳細公司背景可參考: https://www.gtbiopharma.com